As the community ages, the prevalence of intelligent dysfunction increases, making it a major community health concern. Biomarkers that can detect intelligent dysfunction early may supply a window for invasions that could delay or block its progress. This review article analyzes the current state of biomarker research for cognitive dysfunction, containing structural and working neuroimaging, cerebrospinal fluid biomarkers, and blood-located biomarkers. It discusses the strengths and restraints of each type of biomarker and highlights hopeful new areas of research. The item also argues challenges in developing biomarkers for intelligent dysfunction, such as the lack of harmony on diagnostic tests and the need for large, long studies. Overall, the review highlights the potential of biomarkers to develop the diagnosis and situation of cognitive dysfunction and the need for persisted research in this area.
Author(s) Details:
Jerin James,
Department of Pharmacology, SRM Medical College
Hospital and Research Centre, Kattankulathur, Tamilnadu, India.
Jamuna
Rani,
Department
of Pharmacology, SRM Medical College Hospital and Research Centre,
Kattankulathur, Tamilnadu, India.
V. Sathyanarayanan,
Department of Pharmacology, SRM Medical College Hospital and Research
Centre, Kattankulathur, Tamilnadu, India.
Please see the link here: https://stm.bookpi.org/RPST-V9/article/view/10296
No comments:
Post a Comment